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Preoperative neck ultrasound (US) for lateral cervical lymph nodes is recommended for all
patients undergoing thyroidectomy for thyroid malignancy, but it is operator dependent. We
aimed to develop a radiomics signature using US images of the primary tumor to preopera-
tively predict lateral lymph node metastasis (LNM) in patients with conventional papillary
thyroid carcinoma (cPTC).
Methods
Four hundred consecutive cPTC patients from January 2004 to February 2006 were
enrolled as the training cohort, and 368 consecutive cPTC patients from March 2006 to Feb-
ruary 2007 served as the validation cohort. A radiomics signature, which consisted of 14
selected features, was generated by the least absolute shrinkage and selection operator
(LASSO) regression model in the training cohort. The discriminating performance of the
radiomics signature was assessed in the validation cohort with the area under the receiver
operating characteristic curve (AUC).
Results
The radiomics signature was significantly associated with lateral cervical lymph node status
(p < 0.001). The AUC of its performance in discriminating metastatic and non-metastatic lat-
eral cervical lymph nodes was 0.710 (95% CI: 0.649–0.770) in the training cohort and was
0.621 (95% CI: 0.560–0.682) in the validation cohort.
Conclusions
The present study showed that US radiomic features of the primary tumor were associated
with lateral cervical lymph node status. Although their discriminatory performance was
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slightly lower in the validation cohort, our study shows that US radiomic features of the pri-
mary tumor alone have the potential to predict lateral LNM.
Introduction
Papillary thyroid carcinoma (PTC) is the most common histologic type of thyroid malignancy,
and most patients have a favorable prognosis [1]. PTC primarily accounts for the increased
incidence rates of thyroid cancer seen in the past several decades, which is mainly due to the
early detection of small tumors with high-resolution ultrasonography (US) [2,3]. Subsequently,
overall mortality of thyroid cancer has also significantly decreased, with five-year cancer-spe-
cific mortality rates decreasing from 5.9% to 0.2% during the last four decades in South Korea
[3].
However, approximately 13.3% of patients experience recurrence after initial surgery, with
most PTC recurrences occurring in the cervical lymph nodes [3,4]. Although PTC nodal
metastases have little influence on survival, they have been well associated with increased risk
of recurrence and potentially associated with mortality in select patient populations [5,6].
Patients with pathologic lateral lymph node metastasis (LNM) typically require aggressive
treatment, including lateral compartment lymph node dissection and high-dose radioactive
iodine (RAI) therapy [7]. In addition, lateral LNM conveys a higher risk of recurrence than
central LNM, even when treated with therapeutic neck dissection and/or RAI ablation, which
increases morbidity and reduces quality of life [5,8]. Therefore, identification of lateral LNM is
crucial for establishing appropriate management strategies. Preoperative neck US and US-
guided fine-needle aspiration biopsy are the primary tools used for detecting and diagnosing
LNM in patients with thyroid cancer [9]. However, the diagnostic performance of preoperative
neck US differs among physicians, and interobserver variability is highest when determining
lateral LNM [10,11].
Fueled by the exponential growth of medical imaging and developments in analytical meth-
ods, the field of radiomics has attracted increased attention in recent years. Previous studies
have shown that quantitative radiomics features can provide insight into personalized medi-
cine and potentially improve diagnostic, prognostic, and predictive accuracy [12]. Radiomics
signatures, which consist of radiomic features, have been associated with clinical prognosis
across a wide range of cancer types and are conveniently used to facilitate the preoperative
individualized prediction of LNM [13–15]. However, there are only a few studies investigating
the association of US-based radiomic features with LNM in patients with PTC, and fewer or
no studies specifically focusing on lateral LNM [16,17].
Thus, in this study we aimed to develop a radiomics signature using US images to preopera-
tively predict lateral LNM in patients with conventional PTC (cPTC).
Materials and methods
Patients
The Severance Hospital Institutional Review Board approved this retrospective study and
waived the need to obtain informed consent (Approval number: 4-2017-1024). All research
was performed in accordance with relevant guidelines. The training cohort of this study was
consecutive patients with histologically confirmed cPTC who underwent preoperative US and
thyroid surgery from January 2004 to February 2006, and who did not have evidence of distant
metastases at diagnosis. In total, 400 patients were identified and comprised the training
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cohort (342 women and 58 men; mean age, 45.37 years ± 12.90; range, 17 to 80 years). An
independent validation cohort was obtained from 368 consecutive patients (306 women and
62 men; mean age, 44.92 years ± 12.26; range, 18 to 76 years) with surgically confirmed cPTC
from March 2006 to February 2007, using the same criteria as the training cohort.
Total or near-total thyroidectomy was performed in patients either diagnosed or suspected
of having multiple tumors, extrathyroidal extension or LNM upon preoperative evaluation or
intraoperative findings. All patients underwent routine central compartment neck dissection,
including the pretracheal, paratracheal, and prelaryngeal lymph nodes. Bilateral or ipsilateral
central compartment neck dissection was performed in patients undergoing total or near-total
thyroidectomy or in those undergoing hemithyroidectomy, respectively. In patients diagnosed
with lateral LNM by preoperative US-guided fine-needle aspiration, lateral compartment neck
dissection was performed. Intraoperative frozen biopsy was also performed for lymph nodes
suspicious for metastases found during surgery which were not found on preoperative US. If
lateral LNM was confirmed, lateral compartments including levels 2, 3, 4 and anterior 5 were
dissected. Clinicopathologic data were collected by reviewing medical records.
US image acquisition and region-of-interest segmentation
All patients underwent preoperative US of both thyroid glands and the cervical regions, per-
formed by using a 5−13-MHz (SONOLINE Antares; Siemens Medical Solutions, Erlangen,
Germany/ Acuson Sequoia 512; Acuson, Mountain View, CA), a 7−12-MHz (HDI 3000 or
5000; Philips Medical Systems, Bothell, Wash), or a 5−12-MHz linear array transducer (iU22;
Philips Medical Systems, Bothell, Wash). For feature selection, a representative US image was
selected for each tumor. Representative US images were selected from images that were previ-
ously captured by a radiologist at the time of the examination, which were retrieved from the
picture archiving and communication system.
All manual segmentations of the thyroid tumors were performed by a radiologist (V.Y.P.)
who had 9 years of experience in thyroid US imaging by delineating a region of interest (ROI)
around the boundary of the index tumor on the representative US image. Each segmentation
was validated by a senior radiologist (K.J.Y.) who had 18 years of subspecialty experience in
thyroid imaging.
Radiomic feature extraction, selection and building the radiomics
signature
Texture feature extraction was performed by in-house texture analysis algorithms imple-
mented in MATLAB 2016b (The MathWorks, Inc., Natick, Massachusetts, United States). The
ROI-segmented US images were saved as JPG images and then converted into grayscale inten-
sity images by eliminating the hue and saturation information while retaining luminance. In
total, 730 candidate radiomic features, including energy, entropy, kurtosis, features using
GLCM and GLRLM texture matrices, features using single-level discrete 2D wavelet transform
and so on, were generated from a single US image. Each extracted ROI image was normalized
for direct comparison between patients when textural features were calculated. More informa-
tion about the methodology for radiomic feature extraction is described in the S1 Appendix.
We used the least absolute shrinkage and selection operator (LASSO) method in logistic
regression to select the most useful predictive radiomic features for lateral cervical LNM from
the training cohort. The statistical analyses were performed using R software, version 3.3.3
(http://www.R-project.org), where the package ‘glmnet’ was used to apply the LASSO method.
The LASSO method is a penalized technique for variable selection that is suitable for the
regression of high-dimensional data[18]. In the LASSO logistic regression analysis, 10-fold
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cross-validation was used to avoid overfitting. The selected imaging features were then com-
bined into a radiomics signature. Based on the estimated coefficients, we computed a radio-
mics score (Rad-score) for each patient to reflect the risk of lateral LN metastasis. The
predictive accuracy of the radiomics signature was calculated by using the area under the
receiver operating characteristic curve (AUC) in both the training and validation cohorts.
Statistical analysis
The statistical analyses were performed using R software, version 3.3.3 (http://www.R-project.
org), where the package ‘glmnet’ was used to apply the LASSO method. All other statistical
tests were conducted using the basic R functions. Differences in lateral LNM prevalence and
clinicopathologic characteristics between the training and validation cohort were assessed with
the Mann-Whitney U test and the Chi-Square test. A two-sided P< 0.05 was considered statis-
tically significant.
Results
Patient characteristics and thyroid nodules
The clinical characteristics of the training and validation cohorts are given in Table 1. The
training cohort had a larger pathological tumor size than the validation cohort, but the differ-
ence was only 1.2 mm (19.27 mm vs. 18.02 mm, p = 0.007). The validation cohort had a slightly
higher lateral LNM prevalence than the training cohort (21% vs. 27%, p = 0.045). No signifi-
cant differences were found between the two cohorts in terms of age (p = 0.763) and sex
(p = 0.426). We also compared the above basic information between patients with lateral LNM
and without lateral LNM in the training and validation cohorts, respectively. Details are
shown in Table 2.
Feature selection and building the radiomics signature
Based on the training cohort, 727 extracted features were reduced to 14 potential predictors
using the LASSO regression model (Fig 1). These 14 features were included in the Rad-score
calculation formula (S2 Appendix). The Rad-score of each nodule in the training and valida-
tion cohorts was calculated using this formula. Distribution of the Rad-score for patients with
and without lateral LNM in the training and validation cohorts are displayed in Table 2. In
Table 1. Patient and tumor characteristics in the training and validation cohorts.
Training cohort (n = 400) Validation cohort (n = 368) p-value
Age (years) a 45 (35, 54) 46 (35, 53) 0.763
Sex 0.426
Female 342 (86.0%) 306 (83.0%)
Male 58 (14.0%) 62 (17.0%)
Pathological tumor size (mm) � 17 (13, 23) 15 (12, 22) 0.007
Central lymph node metastasis 0.725
Negative 170 (42.5%) 162 (44.0%)
Positive 230 (57.5%) 206 (56.0%)
Lateral lymph node metastasis 0.045
Negative 317 (79.0%) 268 (73.0%)
Positive 83 (21.0%) 100 (27.0%)
�Data are presented as medians with the 1st and 3rd quartiles in parentheses.
https://doi.org/10.1371/journal.pone.0227315.t001
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both cohorts, the Rad-score was significantly different between patients with and without lat-
eral LNM (all p< 0.001).
Radiomics signature discrimination
ROC curves of the radiomics signature were plotted to show the performance of the radiomics
signature in predicting lateral cervical LNM in the training and validation cohorts (Fig 2). In
the training cohort, the radiomics signature yielded an AUC of 0.710 (95% CI: 0.649, 0.770)
for predicting lateral LNM. In the validation cohort, the radiomics signature yielded an AUC
of 0.621 (95% CI: 0.560, 0.682)
Discussion
We developed a radiomics signature as a new approach to preoperatively predict lateral cervi-
cal LNM in cPTC. Our study demonstrated that US radiomic features of the primary tumor
were associated with lateral cervical LNM status and showed that the radiomics signature
could potentially predict lateral LNM in patients with cPTC.
US features suggestive of metastatic LNs have been well established in literature, but no sin-
gle US feature is adequately sensitive for the detection of cervical LNs with metastatic thyroid
cancer [7]. Even when using a combination of suspicious US features, preoperative neck US is
inevitably affected by interobserver variability. Evaluation results for lateral cervical lymph
nodes vary the most among physicians, with the reported positive predictive values ranging
from 38.5% to 64% according to different levels of experience [10]. Previous research has also
focused on US or the pathologic features of the primary thyroid tumor itself, and has reported
that a high suspicion US pattern, upper pole location, extrathyroidal extension, presence of cal-
cifications, and central LNM are associated with lateral LNM [19–21]. However, such qualita-
tive imaging features are also based on the judgment of the performing physician and
therefore, prone to interobserver variability. In contrast, utilizing quantitative imaging features
of the primary tumor enables an approach that is less affected by observer performance and
thus, could be a more promising tool for clinical practice.
Radiomics has recently shown potential for achieving personalized medicine across a wide
range of cancer types and has been reported to facilitate individualized prediction of LNM in
patients with colorectal and bladder cancer [14,22]. However, its potential has been less inves-
tigated in thyroid cancer, and fewer or no studies have focused specifically on its association
Table 2. Patient and tumor characteristics according to lateral cervical lymph node status in the training and validation cohorts.









Age (years)a 47 (33, 56) 45 (36, 54) 0.620 40 (31.25, 49.75) 47 (37, 54) <0.001
Sex 0.491
Female 69 (83.1%) 273 (86.1%) 74 (74.0%) 232 (86.6%) 0.004
Male 14 (16.9%) 44 (13.9%) 26 (26.0%) 36 (13.4%)
Pathological tumor size (mm)a 20 (14, 25) 16 (13, 21) 0.011 17.50 (13, 25) 15 (12, 20) 0.001
Central LN metastasis < 0.001 < 0.001
Negative 8 (9.6%) 162 (51.1%) 13 (13.0%) 149 (55.6%)
Positive 75 (90.4%) 155 (48.9%) 87 (87.0%) 119 (44.4%)
Rad-score� -1.27 (-1.42, -0.97) -1.48 (-1.64, -1.23) < 0.001 -1.21 (-1.40, -1.00) -1.36 (-1.56, -1.09) < 0.001
�Data are presented as medians with the 1st and 3rd quartiles in parentheses.
https://doi.org/10.1371/journal.pone.0227315.t002
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with lateral LNM. Although several previous studies have applied histogram and texture analy-
sis in thyroid nodules, most have investigated only a small number of imaging parameters and
were not based on high-dimensional data [23–28]. Furthermore, the majority of studies apply-
ing histogram or texture analysis have focused on differentiating malignant and benign thy-
roid nodules [23–27,29]. Therefore, in this study, we attempted to develop a radiomics
signature for the prediction of lateral LNM in patients with cPTC based solely on the radiomic
features of the primary thyroid tumor.
In two previous studies that investigated the association between B-mode US-based radio-
mic features of the thyroid tumor and cervical lymph node metastasis in patients with PTC,
the radiomics model showed AUC values ranging from 0.727 to 0.81 [16,17]. These studies dif-
fer from ours in that lymph node metastasis including both central and lateral cervical lymph
Fig 1. Imaging feature selection using the least absolute shrinkage and selection operator (LASSO) logistic regression
model in the training cohort. (A) Tuning parameter (λ) in the LASSO model was selected under the minimum criteria.
The area under the receiver operating characteristic curve (AUC) was plotted versus log (λ). Dotted vertical lines were
drawn at the optimal values by using the minimum criteria and the 1 standard error (SE) of the minimum criteria (1-SE
criteria) according to 10-fold cross validation. (B) LASSO coefficient profiles of the 730 features. A coefficient profile plot
was produced against the log (λ) sequence. Vertical line was drawn at the value selected using 10-fold cross validation,
where optimal λ resulted in 14 nonzero coefficients.
https://doi.org/10.1371/journal.pone.0227315.g001
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nodes was the investigated outcome, and a support vector machine classifier was employed to
build the radiomics models. Interestingly, the performance of the radiomics model was higher
in the study that used one US system without a separate validation set (AUC: 0.81) [16]. The
other study collected images from three different US machines and tested the performance of
the radiomics model in a separate testing cohort, resulting in an AUC value of 0.727, similar to
our study [17]. It has been reported that radiomics models are dependent on the type of the
US machine used, which may partly explain for the fair performance of the radiomics signa-
ture in our study [30]. In addition, our study showed slightly lower discriminative perfor-
mance compared with the prior studies, possibly due to the different primary outcome and
that only first order, textural, and waveleft-based features were utilized to build the radiomics
signature. Other radiomic features which more directly reflect tumor shape, margin or tumor
position may further improve its performance [17]. However, we found that among the 14
selected radiomic features, 10 were waveleft-based features, implying the importance of
including higher-order statistical methods for feature extraction.
A previous meta-analysis reported that US showed an overall AUC of 0.85 in diagnosing
lateral cervical LNM with a sensitivity of 75% (95% CI: 68–75) and a specificity of 97% (95%
CI: 93–99) [9]. Similar results were obtained in a more recent study, in which US demon-
strated a summary sensitivity of 71% (95% CI: 57–82) and a specificity of 85% (95% CI: 64–94)
[31]. Despite its high accuracy, the performance of US is affected by the experience of the phy-
sician—among aspects of staging US, only the performance of diagnosing lateral LNM signifi-
cantly differed between experienced and less experienced physicians [10]. Recently, a pilot
study reported the development of a deep learning-based US computer-aided diagnostic sys-
tem for the diagnosis of metastatic lymph nodes, and the diagnostic system showed an accu-
racy, sensitivity and specificity of 83.0%, 79.5% and 87.5%, respectively [32]. However, this
would still require the observer to detect and image the lymph node for further analysis, and
thus, results would likely be affected by interobserver variability. Although our approach
Fig 2. Receiver operating characteristic curves of the radiomics signature for predicting lateral cervical LNM. (A) Training cohort (AUC: 0.710 [95% CI: 0.649,
0.770]) and (B) validation cohort (AUC: 0.621 [95% CI: 0.560, 0.682]).
https://doi.org/10.1371/journal.pone.0227315.g002
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allows evaluation to be relatively independent from physician experience, its diagnostic perfor-
mance in the validation cohort was slightly lower than the training cohort, achieving an overall
AUC of 0.621. As our study population consisted of patients imaged between 2004 and 2007,
further improvements may be achieved in future studies which utilize images of even higher
image resolution.
The limitations of our study include the retrospective nature of data collection and the lack
of external validation for the model, as we used a validation cohort that was drawn from the
same institution. Another limitation is that lateral compartment neck dissection was selectively
performed in patients diagnosed with lateral LNM by preoperative fine-needle aspiration or
intraoperative frozen biopsy. Considering that subclinical microscopic LNM occurs frequently
in patients with PTC, the number of lateral LNM could have been underestimated. Finally, we
utilized images obtained from several different US systems. Radiomic features have been
reported to be affected by the type of US machine used for image acquisition, and this may
have affected our results. However, our study results also show the potential of building and
applying US-based radiomics signatures using multiple US systems, which could expand its
potential for clinical application.
In conclusion, we developed a US radiomics signature based solely on imaging features of
the primary tumor for the prediction of lateral cervical LNM in patients with cPTC. Although
its discriminatory performance was slightly lower in the validation cohort, our study shows the
potential of applying US radiomic features of the primary tumor alone for the prediction of lat-
eral LNM. More studies are required for further validation and future improvement of radio-
mics-based preoperative prediction in patients with cPTC.
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